Quarterly ResultMay 15, 2026, 04:10 PM
VASO Corp Q1 Net Loss $(0.89)M; Cash Down to $22.0M
AI Summary
VASO Corp reported a net loss of $(0.89) million for Q1 2026, an improvement from $(1.08) million in Q1 2025, despite a slight decrease in total revenues to $19.36 million. Gross profit increased to $11.58 million. However, the company experienced a significant increase in net cash used in operating activities, reaching $(12.63) million, and its cash and cash equivalents decreased to $21.97 million from $35.05 million at year-end 2025.
Key Highlights
- Total revenues for Q1 2026 were $19.36 million, down from $19.46 million in Q1 2025.
- Net loss for Q1 2026 improved to $(0.89) million from $(1.08) million in Q1 2025.
- Loss per common share remained at $(0.01) for both Q1 2026 and Q1 2025.
- Cash and cash equivalents decreased to $21.97 million at March 31, 2026, from $35.05 million at December 31, 2025.
- Net cash used in operating activities significantly increased to $(12.63) million in Q1 2026 from $(0.57) million in Q1 2025.
- Professional sales service revenue increased to $9.24 million in Q1 2026 from $8.71 million in Q1 2025.
- Unfulfilled performance obligations totaled approximately $103 million as of March 31, 2026.
- GE HealthCare accounted for 48% of Q1 2026 revenue and 84% of accounts and other receivables.
Price Impact
More from VASO